OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VIP.NH56

VIP Gloves Ltd

Medical Equipment, Supplies & DistributionVerified

Capital Structure and Liquidity VIP Gloves Ltd exhibits a highly leveraged capital structure, with total liabilities of AUD 4,258,340 and total equity of -AUD 3,551,910, resulting in a negative net worth. The company's liquidity position is weak, as evidenced by a current ratio of 0.16, indicating that it has significantly more current liabilities than current assets. The debt-to-equity ratio of -0.11 further highlights the company's reliance on debt financing, which is exacerbated by a negative equity position. ### Profitability and Returns The company is currently unprofitable, with an operating loss of AUD 479,650 and a net loss of the same amount. Its return on assets (ROA) is -0.679, indicating that the company is generating negative returns on its asset base. The return on equity (ROE) of 0.135 is also negative, reflecting the company's inability to generate returns for its shareholders. These metrics are significantly below the industry median for medical equipment and supplies companies, which typically report positive ROA and ROE figures. ### Segments and Geographic Exposure The company's revenue is concentrated in a single business segment, which is the production and distribution of medical gloves. There is no disclosed geographic diversification in the financial data, suggesting that the company's operations are likely concentrated in a single region, potentially increasing its exposure to local economic and regulatory risks. ### Growth Trajectory The company's financial performance has deteriorated significantly, with a net loss of AUD 479,650 and a free cash flow of -AUD 434,630. The outlook for the current fiscal year is negative, with no indication of improvement in the near term. The company's operating cash flow is also negative, at -AUD 761,520, which further constrains its ability to invest in growth initiatives or service its debt obligations. ### Risk Factors The company faces significant liquidity risk, as it has negative net cash after subtracting total debt. This increases the likelihood of default on its obligations, particularly given its negative equity position. The risk of dilution is currently low, but the company's financial distress may lead to future equity issuances to raise capital, which could dilute existing shareholders. The company's capital structure and negative cash flows also increase its credit risk. ### Recent Events Recent financial filings indicate a continued decline in profitability and liquidity. The company has not disclosed any material events or strategic initiatives that could reverse its current financial trajectory. The absence of positive developments in recent transcripts or filings suggests that the company is struggling to address its operational and financial challenges.

30-day price · VIP.NH+0.00 (+0.0%)
Low$0.07High$0.07Close$0.07As of15 May, 00:00 UTC
Profile
CompanyVIP Gloves Ltd
TickerVIP.NH
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. VIP Gloves Ltd is a medical equipment and supplies company that primarily generates revenue through the production and distribution of gloves used in healthcare settings.

Classification. VIP Gloves Ltd is classified under the Healthcare economic sector, within the Healthcare Services & Equipment business sector, and the Medical Equipment, Supplies & Distribution industry, with a confidence level of 0.92.

### Capital Structure and Liquidity VIP Gloves Ltd exhibits a highly leveraged capital structure, with total liabilities of AUD 4,258,340 and total equity of -AUD 3,551,910, resulting in a negative net worth. The company's liquidity position is weak, as evidenced by a current ratio of 0.16, indicating that it has significantly more current liabilities than current assets. The debt-to-equity ratio of -0.11 further highlights the company's reliance on debt financing, which is exacerbated by a negative equity position. ### Profitability and Returns The company is currently unprofitable, with an operating loss of AUD 479,650 and a net loss of the same amount. Its return on assets (ROA) is -0.679, indicating that the company is generating negative returns on its asset base. The return on equity (ROE) of 0.135 is also negative, reflecting the company's inability to generate returns for its shareholders. These metrics are significantly below the industry median for medical equipment and supplies companies, which typically report positive ROA and ROE figures. ### Segments and Geographic Exposure The company's revenue is concentrated in a single business segment, which is the production and distribution of medical gloves. There is no disclosed geographic diversification in the financial data, suggesting that the company's operations are likely concentrated in a single region, potentially increasing its exposure to local economic and regulatory risks. ### Growth Trajectory The company's financial performance has deteriorated significantly, with a net loss of AUD 479,650 and a free cash flow of -AUD 434,630. The outlook for the current fiscal year is negative, with no indication of improvement in the near term. The company's operating cash flow is also negative, at -AUD 761,520, which further constrains its ability to invest in growth initiatives or service its debt obligations. ### Risk Factors The company faces significant liquidity risk, as it has negative net cash after subtracting total debt. This increases the likelihood of default on its obligations, particularly given its negative equity position. The risk of dilution is currently low, but the company's financial distress may lead to future equity issuances to raise capital, which could dilute existing shareholders. The company's capital structure and negative cash flows also increase its credit risk. ### Recent Events Recent financial filings indicate a continued decline in profitability and liquidity. The company has not disclosed any material events or strategic initiatives that could reverse its current financial trajectory. The absence of positive developments in recent transcripts or filings suggests that the company is struggling to address its operational and financial challenges.
Key takeaways
  • VIP Gloves Ltd is operating at a significant loss, with a net loss of AUD 479,650 and a negative return on assets of -0.679.
  • The company's liquidity position is weak, with a current ratio of 0.16 and a negative net worth.
  • The company's revenue is concentrated in a single business segment, increasing its exposure to sector-specific risks.
  • The outlook for the company is negative, with no indication of improvement in the near term.
  • The company faces significant liquidity and credit risks, which could lead to default on its obligations.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue$1.5M
Gross profit$16.1k
Operating income-$479.6k
Net income-$479.6k
R&D
SG&A
D&A
SBC
Operating cash flow-$761.5k
CapEx-$4.7k
Free cash flow-$434.6k
Total assets$706.4k
Total liabilities$4.3M
Total equity-$3.6M
Cash & equivalents
Long-term debt$383.5k
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$3.6M
Net cash-$383.5k
Current ratio0.2
Debt/Equity-0.1
ROA-67.9%
ROE13.5%
Cash conversion1.6%
CapEx/Revenue-0.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricVIP.NHActivity
Op margin-31.7%3.9% medp25 -31.3% · p75 14.4%bottom quartile
Net margin-31.7%2.4% medp25 -30.5% · p75 11.1%bottom quartile
Gross margin1.1%46.7% medp25 28.2% · p75 63.1%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-0.3%-4.8% medp25 -11.6% · p75 -2.4%top quartile
Debt / equity-11.0%17.9% medp25 2.7% · p75 52.2%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-15 16:54 UTC#8cf4fbd5
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 22:39 UTCJob: 6c34ea42